Showing results (21-30 of 52) with videos related to
Sort By:
Pageof 6
Arthritis Research & Therapy|December 15, 2006
HLA-C locus alleles may modulate the clinical expression of psoriatic arthritisRuben Queiro, Segundo Gonzalez, Carlos López-Larrea, et al.Cancers|January 2, 2019
NK Cell-Based Immunotherapy in Cancer MetastasisSeila Lorenzo-Herrero, Alejandro López-Soto, Christian Sordo-Bahamonde, et al.Self/Nonself|July 22, 2011
Conceptual aspects of self and nonself discriminationSegundo Gonzalez, Ana Pilar González-Rodríguez, Beatriz Suárez-Álvarez, et al.Frontiers in Immunology|April 9, 2014
Molecular Bases for the Regulation of NKG2D Ligands in CancerLeticia Huergo-Zapico, Andrea Acebes-Huerta, Alejandro López-Soto, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 20, 2013
Epithelial-mesenchymal transition induces an antitumor immune response mediated by NKG2D receptorAlejandro López-Soto, Leticia Huergo-Zapico, José Alberto Galván, et al.Oncoimmunology|April 9, 2016
Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptorsAndrea Acebes-Huerta, Seila Lorenzo-Herrero, Alicia R Folgueras, et al.Cancers|April 30, 2021
LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic LeukemiaChristian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P González-Rodríguez, et al.Biomed Research International|October 15, 2014
Lenalidomide induces immunomodulation in chronic lymphocytic leukemia and enhances antitumor immune responses mediated by NK and CD4 T cellsAndrea Acebes-Huerta, Leticia Huergo-Zapico, Ana Pilar Gonzalez-Rodriguez, et al.Cancers|April 30, 2021
BTLA/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic LeukemiaChristian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P Gonzalez-Rodriguez, et al.Biomed Research International|October 29, 2013
Lenalidomide and chronic lymphocytic leukemiaAna Pilar González-Rodríguez, Angel R Payer, Andrea Acebes-Huerta, et al.Pageof 6